CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 65 filers reported holding CUE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | +24.4% | 22,317 | +92.6% | 0.00% | – |
| Q1 2023 | $41 | -99.9% | 11,586 | -29.4% | 0.00% | – |
| Q3 2022 | $36,000 | -18.2% | 16,400 | -8.0% | 0.00% | – |
| Q2 2022 | $44,000 | +238.5% | 17,820 | +532.6% | 0.00% | – |
| Q1 2022 | $13,000 | -90.0% | 2,817 | -75.6% | 0.00% | – |
| Q4 2021 | $130,000 | +44.4% | 11,535 | +55.6% | 0.00% | – |
| Q3 2021 | $90,000 | +13.9% | 7,411 | +8.8% | 0.00% | – |
| Q2 2021 | $79,000 | -34.7% | 6,811 | -31.3% | 0.00% | – |
| Q1 2021 | $121,000 | +1110.0% | 9,921 | +2124.4% | 0.00% | – |
| Q2 2020 | $10,000 | -23.1% | 446 | -54.7% | 0.00% | – |
| Q1 2020 | $13,000 | – | 984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |